Scintigraphy assessment of pulmonary delivery systems

Pharmaceutical Technology

Volumn 22, Issue 6, 1998, Pages 78-94

  Newman, Stephen P ^a  

^a PHARMACEUTICAL PROFILES LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; CHLOROFLUOROCARBON;

AEROSOL; BIOEQUIVALENCE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRY DEPOSITION; GAMMA SCINTIGRAPHY; HUMAN; HUMAN EXPERIMENT; INHALATIONAL DRUG ADMINISTRATION; LUNG; NORMAL HUMAN; OROPHARYNX; REVIEW;

EID: 0031837896     PISSN: 01478087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. R.K. Wolff and R.W. Niven, "Generation of Aerosolized Drugs," J. Aerosol Med. 7, 89-106 (1994).
2. I.J. Smith, "The Challenge of Reformulation," J. Aerosol Med. 8, S19-S27 (1995).
3. C. Leach, "Enhanced Drug Delivery through Reformulating MDIs with HFA Propellants - Drug Deposition and Its Effect on Preclinical and Clinical Programs," in Respiratory Drug Delivery V, R.N. Dalby, P.R. Byron, and S.J. Farr, Eds. (Interpharm, Buffalo Grove, IL, 1996), pp. 133-144.
4. A.R. Clark, "Medical Aerosol Inhalers: Past, Present, and Future," Aerosol Sci. Technol. 22, 374-391 (1995).
5. R.W. Niven, "Delivery of Biotherapeutics by Inhalation Aerosol," Crit. Rev. Ther. Drug Carrier Sys. 12, 151-231 (1995).
6. S.J. Farr et al., "AER-X Development of a Novel Liquid Aerosol Delivery System: Concept to Clinic," in Respiratory Drug Delivery V, R.N. Dalby, P.R. Byron, and S.J. Farr, Eds. (Interpharm, Buffalo Grove, IL, 1996), pp. 175-185.
7. B. Zierenberg et al., "Boehringer Ingelheim Nebulizer BINEB. A New Approach to Inhalation Therapy," in Respiratory Drug Delivery V, R.N. Dalby, P.R. Byron, and S.J. Farr, Eds. (Interpharm, Buffalo Grove, PL, 1996), pp. 187-193.
8. P.R. Byron and J.S. Patton, "Drug Delivery via the Respiratory Tract," J. Aerosol Med. 7, 49-75 (1994).
9. P.L. Smith, "Peptide Delivery via the Pulmonary Route: A Valid Approach for Local and Systemic Delivery," J. Controlled Rel. 46, 99-106 (1997).
10. A.C. Perkins, Nuclear Medicine: Science and Safety (John Libbey, London, 1995).
11. C.G. Wilson et al., Radionuclide Imaging in Drug Research (Croom Helm, London, 1982).
12. S.S. Davis et al., "Gamma Scintigraphy in the Evaluation of Pharmaceutical Dosage Forms," Eur. J. Nucl. Med. 19, 971-986 (1992).
13. G. Meseguer, R. Gurny, and P. Buri, "In Vivo Evaluation of Dosage Forms: Application of Gamma Scintigraphy to Nonenteral Routes of Administration," J. Drug Targeting 2, 269-288 (1994).
14. C.G. Wilson, "Application of Gamma Scintigraphy to Modern Dosage Form Design," Eur. J. Pharm. Sci. 2, 47-49 (1994).
15. J. Brown et al., "Spreading and Retention of Vaginal Formulations in Postmenopausal Women As Assessed by Gamma Scintigraphy," Pharm. Res., 14, 1073-1076 (1997).
16. I. Gonda, "Scintigraphic Techniques for Measuring In Vivo Deposition," J. Aerosol Med. 9 (Supplement 1): S59-S67 (1996).
17. G.C. Smaldone, "Factors in Measurement of Dose by Gamma Scintigraphy," J. Aerosol Med. 9 (Supplement 1): S69-S76 (1996).
18. G.C. Smaldone et al., "Factors Determining Pulmonary Deposition of Aerosolized Pentamidine in Patients with Human Immunodeficiency Virus Infection," Amer. Rev. Respir. Dis. 143, 727-737 (1991).
19. S.P. Newman et al., "Comparison of Gamma Scintigraphy and a Pharmacokinetic Technique for Assessing Pulmonary Deposition of Terbutaline Sulphate Delivered by Pressurized Metered Dose Inhaler," Pharm. Res. 12, 231-236 (1995).
20. S.P. Newman, "The Correct Use of Inhalers," in Steroids in Asthma, T.J.H. Clark, Ed. (Adis Press, Aukland, 1982), pp. 210-226.
21. S.P. Newman et al., "Improvement of Drug Delivery with a Breath-Actuated Pressurised Aerosol for Patients with Poor Inhaler Technique," Thorax 46, 712-716 (1991).
22. J.E. Agnew et al., "Functional Small Airways Defence in Symptomless Cigarette Smokers," Thorax 41, 524-530 (1986).
23. G. Taylor, P. Colthorpe, and S.J. Farr, "Pulmonary Absorption of Proteins: Influence of Deposition Site and Competitive Elimination Processes," in Respiratory Drug Delivery IV, P. Byron, R.N. Dalby, and S.J. Farr, Eds. (Interpharm, Buffalo Grove, IL, 1994), pp. 25-30.
24. S.P. Newman et al., "Pressurised Aerosol Deposition in the Human Lung with and without an 'Open' Spacer," Thorax 44, 706-710 (1989).
25. 99mTc," J. Aerosol Med. 9 (Supplement 1): S27-S36 (1996).
26. S.P. Newman, "Characteristics of Radio-labelled Versus Unlabelled Formulations." J. Aerosol Med. 9 (Supplement 1): S37-S47 (1996).
27. G.R. Pitcairn and S.P. Newman. "Tissue Attenuation Corrections in Gamma Scintigraphy," J. Aerosol Med. 10, 187-198 (1997).
28. S. Perring et al., "A New Method of Quantification of the Pulmonary Regional Distribution of Aerosols Using Combined CT and SPECT and Its Application to Nedocromil Sodium Administered by Metered Dose Inhaler," Br. J. Radiol. 67, 46-53 (1994).
29. C.G. Rhodes and J.M.B. Hughes. "Pulmonary Studies Using Positron Emission Tomography," Eur. Respir. J. 8, 1001-1017 (1995).
30. S.P. Newman and I.R. Wilding, "The Importance of Gamma Scintigraphy in Pharmaceutical Development," J. Pharm. Med. 6, 21-33 (1996).
31. British Association for Lung Research, "Consensus Statement. Determining Equivalence of Inhaled Medications," Respir. Med. 89, 253-261 (1995).
32. S.P. Newman, "Scintigraphic Assessment of Therapeutic Aerosols," Crit. Rev. Ther. Drug Carrier Sys. 10, 65-109 (1993).
33. S.P. Newman, A. Hollingworth, and A.R. Clark, "Effect of Different Modes of Inhalation on Drug Delivery from a Dry Powder Inhaler," Int. J. Pharm. 102, 127-132 (1994).
34. L. Borgström et al., "Lung Deposition of Budesonide Inhaled via Turbuhaler: A Comparison with Terbutaline Sulphate in Normal Subjects," Eur. Respir. J. 7, 69-73 (1994).
35. G.R. Pitcairn et al., "Pulmonary Delivery of Budesonide from the Taifun Dry Powder Inhaler," J. Aerosol Med., 10, 269 (1997).
36. S.P. Newman, "How Well Do In Vitro Particle Size Measurements Predict Drug Delivery In Vivo?" Proceedings of ISAM Workshop Puerto Rico 1997, in press.
37. B. Olsson et al., "Effect of Inlet Throat on the Correlation between Measured Fine Particle Dose and Lung Deposition," in Respiratory Drug Delivery V, R.N. Dalby, P.R. Byron, and S.J. Farr, Eds. (Interpharm, Buffalo Grove, IL, 1996), pp. 273-281.
38. D. Keeley and J. Rees., "New Guidelines on Asthma Management," Br. Med. J. 314, 315-316 (1997).
39. S.P. Newman et al., "Efficient Delivery to the Lungs of Flunisolide Aerosol from the BINEB. A New Portable Hand-Held Multidose Nebuliser System," J. Pharm. Sci. 85, 960-964 (1996).
40. Committee for Proprietary Medicinal Products (CPMP), "Clinical Requirements for Locally Applied, Locally Acting Products Containing Known Constituents" (London, 1995).
41. P. Zanen and J.W.J. Lammers. "Sample Sizes for Comparative Inhaled Corticosteroid Trials with Emphasis on Showing Therapeutic Equivalence," Eur. J. Clin. Pharmacol. 48, 179-184 (1995).